Page last updated: 2024-08-22

cladribine and Enteropathy-Associated T-Cell Lymphoma

cladribine has been researched along with Enteropathy-Associated T-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allez, M; Amiot, A; Bouhnik, Y; Fieschi, C; Galicier, L; Gornet, JM; Joly, F; LĂ©mann, M; Oksenhendler, E; Treton, X1

Other Studies

1 other study(ies) available for cladribine and Enteropathy-Associated T-Cell Lymphoma

ArticleYear
High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphoma.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012, Volume: 44, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Disease Progression; Disease-Free Survival; Enteropathy-Associated T-Cell Lymphoma; Female; Humans; Kaplan-Meier Estimate; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Neutropenia; Purine Nucleotides; Retrospective Studies

2012